{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:38:56Z","timestamp":1792593536338,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Autism Dev Disord"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Current evidence suggests the possibility that autistic people may be at more risk of COVID-19 infection, hospitalisation, and mortality than the general population. Previous studies, however, are either limited in scale or do not investigate potential risk factors. Research into risk factors focused on general population samples. The current study aims to investigate these risk factors in the autistic population. Using data-linkage and a whole-country population, this study modelled associations between autism and COVID-19 hospitalisation and mortality risk in adults, investigating a multitude of clinical and demographic risk factors. Autistic adults had higher rates of hospitalisation, Standardised Incident Ratio 1.6 in 2020 and 1.3 in 2021, and mortality, Standardised Mortality Ratio 1.52 in 2020 and 1.34 in 2021, due to COVID-19 than the general population. In both populations, age, complex multimorbidity and vaccination status were the most significant predictors of COVID-19 hospitalisation and mortality. Effects of psychotropic medication varied by class. Although similar factors exhibited a positive association with heightened risk of severe COVID-19 in both the autistic and general populations, with comparable effect sizes, mortality rates were elevated among the autistic population compared to the general population. Specifically, complex multimorbidity and classification of prescribed medications may emerge as particularly significant predictors of severe COVID-19 among individuals within the autistic population due to higher prevalence of complex multimorbidity in the autistic population and variability in the association between medication classes and severe COVID-19 between both populations, though further research is needed.<\/jats:p>","DOI":"10.1007\/s10803-025-06844-6","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T14:09:48Z","timestamp":1747836588000},"page":"4451-4462","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Population-Based Cross-Sectional Investigation of COVID-19 Hospitalizations and Mortality Among Autistic People"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4846-3242","authenticated-orcid":false,"given":"Dewy","family":"Nijhof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0557-173X","authenticated-orcid":false,"given":"Filip","family":"Sosenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5381-7098","authenticated-orcid":false,"given":"Daniel","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2185-4502","authenticated-orcid":false,"given":"Michael","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7348-514X","authenticated-orcid":false,"given":"Bhautesh D.","family":"Jani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8898-7035","authenticated-orcid":false,"given":"Jill P","family":"Pell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8781-8486","authenticated-orcid":false,"given":"Chris","family":"Hatton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2626-1554","authenticated-orcid":false,"given":"Deborah","family":"Cairns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0880-0662","authenticated-orcid":false,"given":"Laura McKernan","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9749-3133","authenticated-orcid":false,"given":"Ewelina","family":"Rydzewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0975-5971","authenticated-orcid":false,"given":"Maria","family":"Gardani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2580-4035","authenticated-orcid":false,"given":"Elliot","family":"Millington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7234-2382","authenticated-orcid":false,"given":"Craig","family":"Melville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the CVD-COVID-UK\/COVID-IMPACT Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"6844_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Publishing.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"6844_CR2","unstructured":"BHF Data Science Centre. (n.d.). https:\/\/bhfdatasciencecentre.org\/"},{"key":"6844_CR7","unstructured":"British Heart Foundation Data Science Centre. (n.d.). https:\/\/bhfdatasciencecentre.org\/areas\/cvd-covid-uk-covid-impact\/"},{"issue":"7","key":"6844_CR3","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3390\/BRAINSCI11070860","volume":"11","author":"N Brondino","year":"2021","unstructured":"Brondino, N., Bertoglio, F., Forneris, F., Faravelli, S., Borghesi, A., Damiani, S., Provenzani, U., Nola, M., Olivola, M., Caviglia, M., Politi, P., Fusar-Poli, L., & Fusar-Poli, P. (2021). A pilot study on Covid and autism: Prevalence, clinical presentation and vaccine side effects. Brain Sciences, 11(7), 860. https:\/\/doi.org\/10.3390\/BRAINSCI11070860","journal-title":"Brain Sciences"},{"issue":"1","key":"6844_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-91953-2","volume":"11","author":"MD Cantudo-Cuenca","year":"2021","unstructured":"Cantudo-Cuenca, M. D., Guti\u00e9rrez-Pizarraya, A., Pinilla-Fern\u00e1ndez, A., Contreras-Mac\u00edas, E., Fern\u00e1ndez-Fuertes, M., Lao-Dom\u00ednguez, F. A., Rinc\u00f3n, P., Pineda, J. A., Mac\u00edas, J., & Morillo-Verdugo, R. (2021). Drug\u2013drug interactions between treatment specific pharmacotherapy and concomitant medication in patients with COVID-19 in the first wave in Spain. Scientific Reports, 11(1), 1\u20138. https:\/\/doi.org\/10.1038\/s41598-021-91953-2","journal-title":"Scientific Reports"},{"key":"6844_CR5","doi-asserted-by":"publisher","DOI":"10.1192\/bja.2021.32","author":"E Carthy","year":"2021","unstructured":"Carthy, E., Ross, C., & Murphy, D. (2021). Psychotropic medication prescribing in people with autism spectrum disorders with and without psychiatric comorbidity. Bjpsych Advances. https:\/\/doi.org\/10.1192\/bja.2021.32","journal-title":"Bjpsych Advances"},{"issue":"669","key":"6844_CR6","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.3399\/BJGP18X695465","volume":"68","author":"A Cassell","year":"2018","unstructured":"Cassell, A., Edwards, D., Harshfield, A., Rhodes, K., Brimicombe, J., Payne, R., & Griffin, S. (2018). The epidemiology of multimorbidity in primary care: A retrospective cohort study. British Journal of General Practice, 68(669), e245\u2013e251. https:\/\/doi.org\/10.3399\/BJGP18X695465","journal-title":"British Journal of General Practice"},{"issue":"11","key":"6844_CR8","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1176\/APPI.AJP.2020.20060780\/SUPPL_FILE\/APPI.AJP.2020.20060780.DS001.PDF","volume":"177","author":"JN Constantino","year":"2020","unstructured":"Constantino, J. N., Sahin, M., Piven, J., Rodgers, R., & Tschida, J. (2020). The impact of COVID-19 on individuals with intellectual and developmental disabilities: Clinical and scientific priorities. American Journal of Psychiatry, 177(11), 1091\u20131093. https:\/\/doi.org\/10.1176\/APPI.AJP.2020.20060780\/SUPPL_FILE\/APPI.AJP.2020.20060780.DS001.PDF","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"6844_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000048665","volume":"45","author":"J Croonenberghs","year":"2002","unstructured":"Croonenberghs, J., Bosmans, E., Deboutte, D., Kenis, G., & Maes, M. (2002). Activation of the inflammatory response system in Autism. Neuropsychobiology, 45(1), 1\u20136. https:\/\/doi.org\/10.1159\/000048665","journal-title":"Neuropsychobiology"},{"key":"6844_CR10","doi-asserted-by":"publisher","first-page":"109899","DOI":"10.1016\/J.MEHY.2020.109899","volume":"144","author":"ME de Lima","year":"2020","unstructured":"de Lima, M. E., & S., Barros, L. C. M., & Arag\u00e3o, G. F. (2020). Could autism spectrum disorders be a risk factor for COVID-19? Medical Hypotheses, 144, 109899. https:\/\/doi.org\/10.1016\/J.MEHY.2020.109899","journal-title":"Medical Hypotheses"},{"issue":"6","key":"6844_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S2215-0366(20)30197-8","volume":"7","author":"AA Eshraghi","year":"2020","unstructured":"Eshraghi, A. A., Li, C., Alessandri, M., Messinger, D. S., Eshraghi, R. S., Mittal, R., & Armstrong, F. D. (2020). COVID-19: Overcoming the challenges faced by individuals with autism and their families. The Lancet Psychiatry, 7(6), 481\u2013483. https:\/\/doi.org\/10.1016\/S2215-0366(20)30197-8","journal-title":"The Lancet Psychiatry"},{"key":"6844_CR16","doi-asserted-by":"publisher","first-page":"102165","DOI":"10.1016\/j.rasd.2023.102165","volume":"105","author":"L Forsyth","year":"2023","unstructured":"Forsyth, L., Mcsorley, M., & Rydzewska, E. (2023). All-cause and cause-specific mortality in people with autism spectrum disorder: A systematic review. Research in Autism Spectrum Disorders, 105, 102165. https:\/\/doi.org\/10.1016\/j.rasd.2023.102165","journal-title":"Research in Autism Spectrum Disorders"},{"issue":"4\u20135","key":"6844_CR17","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1080\/08959420.2020.1750543","volume":"32","author":"W Gardner","year":"2020","unstructured":"Gardner, W., States, D., & Bagley, N. (2020). The coronavirus and the risks to the elderly in long-term care. Journal of Aging & Social Policy, 32(4\u20135), 310\u2013315. https:\/\/doi.org\/10.1080\/08959420.2020.1750543","journal-title":"Journal of Aging & Social Policy"},{"key":"6844_CR18","unstructured":"Github analysis plan. (n.d.). https:\/\/github.com\/BHFDSC\/CCU030_02"},{"key":"6844_CR19","unstructured":"Glover, G., Williams, R., Branford, D., Avery, R., Chauhan, U., Hoghton, M., & Bernard, S. (2015). Prescribing of psychotropic drugs to people with learning disabilities and\/or autism by general practitioners in England."},{"key":"6844_CR20","unstructured":"GOV.UK. (n.d.). 2 Years of COVID-19 on GOV.UK - Government Digital Service. Retrieved September 7, 2023, from https:\/\/gds.blog.gov.uk\/2022\/07\/25\/2-years-of-covid-19-on-gov-uk\/"},{"issue":"6","key":"6844_CR21","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1136\/JECH-2021-218192","volume":"76","author":"A Henderson","year":"2022","unstructured":"Henderson, A., Fleming, M., Cooper, S. A., Pell, J. P., Melville, C., MacKay, D. F., Hatton, C., & Kinnear, D. (2022). COVID-19 infection and outcomes in a population-based cohort of 17 203 adults with intellectual disabilities compared with the general population. Journal of Epidemiology and Community Health, 76(6), 550\u2013555. https:\/\/doi.org\/10.1136\/JECH-2021-218192","journal-title":"Journal of Epidemiology and Community Health"},{"key":"6844_CR22","doi-asserted-by":"publisher","first-page":"5199","DOI":"10.1038\/s41380-021-01021-4","volume":"26","author":"N Hoertel","year":"2021","unstructured":"Hoertel, N., S\u00e1nchez-Rico, M., Vernet, R., Beeker, N., Jannot, A.-S., Neuraz, A., Salamanca, E., Paris, N., Daniel, C., Gramfort, A., Lemaitre, G., Bernaux, M., Bellamine, A., Lemogne, C., Airagnes, G., Burgun, A., & Limosin, F. (2021). Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: Results from an observational study. Molecular Psychiatry, 26, 5199\u20135212. https:\/\/doi.org\/10.1038\/s41380-021-01021-4","journal-title":"Molecular Psychiatry"},{"key":"6844_CR23","doi-asserted-by":"publisher","DOI":"10.31124\/ADVANCE.11497014.V2","author":"M Hossain","year":"2020","unstructured":"Hossain, M., Khan, N., Sultana, A., Ma, P., Lisako, E., Mckyer, J., Ahmed, H. U., & Purohit, N. (2020). Prevalence of comorbid psychiatric disorders among people with autism spectrum disorder: An umbrella review of systematic reviews and meta-analyses. Psychiatry Research. https:\/\/doi.org\/10.31124\/ADVANCE.11497014.V2","journal-title":"Psychiatry Research"},{"key":"6844_CR24","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.15324","author":"G Iaccarino","year":"2020","unstructured":"Iaccarino, G., Grassi, G., Borghi, C., Ferri, C., Salvetti, M., & Volpe Massimo, M. (2020). Age and multimorbidity predict death among COVID-19 patients. Hypertension. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.15324","journal-title":"Hypertension"},{"issue":"11","key":"6844_CR25","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/JIR.12776","volume":"64","author":"S Jeste","year":"2020","unstructured":"Jeste, S., Hyde, C., Distefano, C., Halladay, A., Ray, S., Porath, M., Wilson, R. B., & Thurm, A. (2020). Changes in access to educational and healthcare services for individuals with intellectual and developmental disabilities during COVID-19 restrictions. Journal of Intellectual Disability Research, 64(11), 825\u2013833. https:\/\/doi.org\/10.1111\/JIR.12776","journal-title":"Journal of Intellectual Disability Research"},{"issue":"4","key":"6844_CR26","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1177\/1362361315588200","volume":"20","author":"L Kenny","year":"2015","unstructured":"Kenny, L., Hattersley, C., Molins, B., Buckley, C., Povey, C., & Pellicano, E. (2015). Which terms should be used to describe autism? Perspectives from the community. Autism, 20(4), 442\u2013462.","journal-title":"Autism"},{"issue":"2","key":"6844_CR27","first-page":"e018292","volume":"8","author":"D Kinnear","year":"2018","unstructured":"Kinnear, D., Morrison, J., Allan, L., Henderson, A., Smiley, E., & Cooper, S. A. (2018). Prevalence of physical conditions and multimorbidity in a cohort of adults with intellectual disabilities with and without Down syndrome: Cross-sectional study. British Medical Journal Open, 8(2), e018292.","journal-title":"British Medical Journal Open"},{"issue":"2","key":"6844_CR28","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/S10803-021-05187-2\/TABLES\/4","volume":"53","author":"I Krieger","year":"2023","unstructured":"Krieger, I., Erez, G., Weinstein, O., Cohen, A. D., & TzurBitan, D. (2023). COVID-19 morbidity among individuals with Autistic spectrum disorder: A matched controlled population-based study. Journal of Autism and Developmental Disorders, 53(2), 789\u2013794. https:\/\/doi.org\/10.1007\/S10803-021-05187-2\/TABLES\/4","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"9920","key":"6844_CR29","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(13)61539-1","volume":"383","author":"MC Lai","year":"2014","unstructured":"Lai, M. C., Lombardo, M. V., & Baron-Cohen, S. (2014). Autism. The Lancet, 383(9920), 896\u2013910. https:\/\/doi.org\/10.1016\/S0140-6736(13)61539-1","journal-title":"The Lancet"},{"issue":"3","key":"6844_CR30","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/J.RASD.2012.03.005","volume":"6","author":"JK Lake","year":"2012","unstructured":"Lake, J. K., Balogh, R., & Lunsky, Y. (2012). Polypharmacy profiles and predictors among adults with autism spectrum disorders. Research in Autism Spectrum Disorders, 6(3), 1142\u20131149. https:\/\/doi.org\/10.1016\/J.RASD.2012.03.005","journal-title":"Research in Autism Spectrum Disorders"},{"key":"6844_CR31","unstructured":"Laporte, J. R., & Healy, D. (2020). Medications compromising Covid infections. RxISK | Prescription Drug Side Effects. https:\/\/rxisk.org\/medications-compromising-covid-infections\/"},{"issue":"3","key":"6844_CR32","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/JMV.26424","volume":"93","author":"J Li","year":"2021","unstructured":"Li, J., Huang, D. Q., Zou, B., Yang, H., Hui, W. Z., Rui, F., Yee, N. T. S., Liu, C., Nerurkar, S. N., Kai, J. C. Y., Teng, M. L. P., Li, X., Zeng, H., Borghi, J. A., Henry, L., Cheung, R., & Nguyen, M. H. (2021). Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes. Journal of Medical Virology, 93(3), 1449\u20131458. https:\/\/doi.org\/10.1002\/JMV.26424","journal-title":"Journal of Medical Virology"},{"issue":"1","key":"6844_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12877-017-0621-2\/TABLES\/1","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon, N., Shakib, S., Kalisch-Ellett, L., & Caughey, G. E. (2017). What is polypharmacy? A systematic review of definitions. BMC Geriatrics, 17(1), 1\u201310. https:\/\/doi.org\/10.1186\/S12877-017-0621-2\/TABLES\/1","journal-title":"BMC Geriatrics"},{"key":"6844_CR34","doi-asserted-by":"publisher","first-page":"100097","DOI":"10.1016\/J.BBIH.2020.100097","volume":"6","author":"M May","year":"2020","unstructured":"May, M., Slitzky, M., Rostama, B., Barlow, D., & Houseknecht, K. L. (2020). Antipsychotic-induced immune dysfunction: A consideration for COVID-19 risk. Brain, Behavior, & Immunity - Health, 6, 100097. https:\/\/doi.org\/10.1016\/J.BBIH.2020.100097","journal-title":"Brain, Behavior, & Immunity - Health"},{"issue":"1","key":"6844_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12916-021-01907-8\/TABLES\/5","volume":"19","author":"PM McKeigue","year":"2021","unstructured":"McKeigue, P. M., Kennedy, S., Weir, A., Bishop, J., McGurnaghan, S. J., McAllister, D., Robertson, C., Wood, R., Lone, N., Murray, J., Caparrotta, T. M., Smith-Palmer, A., Goldberg, D., McMenamin, J., Guthrie, B., Hutchinson, S., & Colhoun, H. M. (2021). Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: The REACT-SCOT case-control study. BMC Medicine, 19(1), 1\u201311. https:\/\/doi.org\/10.1186\/S12916-021-01907-8\/TABLES\/5","journal-title":"BMC Medicine"},{"key":"6844_CR36","unstructured":"Mehta, H., & Glover, G. (2019). Psychotropic drugs and people with learning disabilities or autism. Public Health England. https:\/\/www.gov.uk\/government\/publications\/psychotropic-drugs-and-people-with-learning-disabilities-or-autism\/psychotropic-drugs-and-people-with-learning-disabilities-or-autism-discussion#citation"},{"key":"6844_CR37","doi-asserted-by":"publisher","first-page":"561882","DOI":"10.3389\/FPSYT.2020.561882\/BIBTEX","volume":"11","author":"T Mutluer","year":"2020","unstructured":"Mutluer, T., Doenyas, C., & Aslan Genc, H. (2020). Behavioral implications of the Covid-19 process for Autism spectrum disorder, and individuals\u2019 comprehension of and reactions to the pandemic conditions. Frontiers in Psychiatry, 11, 561882. https:\/\/doi.org\/10.3389\/FPSYT.2020.561882\/BIBTEX","journal-title":"Frontiers in Psychiatry"},{"key":"6844_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0267423","author":"HI Nakhaee","year":"2022","unstructured":"Nakhaee, H. I., Zangiabadian, M. I., Bayati, R., Rahmanian, M., GhaffariJolfayi, A., & Rakhshanderou, S. (2022). The effect of antidepressants on the severity of COVID-19 in hospitalized patients: A systematic review and meta-analysis. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0267423","journal-title":"PLoS ONE"},{"key":"6844_CR11","unstructured":"NHS Digital. (n.d.).\u00a0General Practice Extraction Service (GPES) Data for pandemic planning and research: a guide for analysts and users of the data. Retrieved\u00a0June\u00a020, 2023, from\u00a0https:\/\/digital.nhs.uk\/coronavirus\/gpes-data-for-pandemic-planning-and-research\/guide-for-analysts-and-users-of-the-data"},{"key":"6844_CR12","unstructured":"NHS Digital DARS. (n.d.). https:\/\/digital.nhs.uk\/services\/data-access-request-service-dars\/dars-products-and-services)."},{"key":"6844_CR13","unstructured":"NHS England IGARD. (n.d.). https:\/\/digital.nhs.uk\/about-nhs-digital\/corporate-information-and-documents\/independent-group-advising-on-the-release-of-data"},{"key":"6844_CR14","unstructured":"NHS England Secure Data Environment Service. (n.d.). https:\/\/digital.nhs.uk\/services\/secure-data-environment-service"},{"issue":"6","key":"6844_CR39","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/S11606-012-2262-7\/TABLES\/4","volume":"28","author":"C Nicolaidis","year":"2013","unstructured":"Nicolaidis, C., Raymaker, D., McDonald, K., Dern, S., Boisclair, W. C., Ashkenazy, E., & Baggs, A. (2013). Comparison of healthcare experiences in autistic and non-autistic adults: A cross-sectional online survey facilitated by an academic-community partnership. Journal of General Internal Medicine, 28(6), 761\u2013769. https:\/\/doi.org\/10.1007\/S11606-012-2262-7\/TABLES\/4","journal-title":"Journal of General Internal Medicine"},{"issue":"2","key":"6844_CR40","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/S00213-020-05716-4","volume":"238","author":"BO Plasencia-Garc\u00eda","year":"2021","unstructured":"Plasencia-Garc\u00eda, B. O., Rodr\u00edguez-Men\u00e9ndez, G., Rico-Rangel, M. I., Rubio-Garc\u00eda, A., Torell\u00f3-Iserte, J., & Crespo-Facorro, B. (2021). Drug-drug interactions between COVID-19 treatments and antipsychotics drugs: Integrated evidence from 4 databases and a systematic review. Psychopharmacology (Berl), 238(2), 329\u2013340. https:\/\/doi.org\/10.1007\/S00213-020-05716-4","journal-title":"Psychopharmacology (Berl)"},{"issue":"14","key":"6844_CR41","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.3390\/IJERPH17145171","volume":"17","author":"B Poblador-Plou","year":"2020","unstructured":"Poblador-Plou, B., Carmona-P\u00edrez, J., Ioakeim-Skoufa, I., Poncel-Falc\u00f3, A., Bliek-Bueno, K., Cano-Del Pozo, M., Gimeno-Feli\u00fa, L. A., Gonz\u00e1lez-Rubio, F., Aza-Pascual-salcedo, M., Bandr\u00e9s-Liso, A. C., D\u00edez-Manglano, J., Marta-Moreno, J., Mucherino, S., Gimeno-Miguel, A., Prados-Torres, A., Clerencia-Sierra, M., Coscollar-Santaliestra, C., de Alba, I. G. F., Moreno-Juste, A., & Ara-Bardaj\u00ed, P. (2020). Baseline chronic comorbidity and mortality in laboratory-confirmed COVID-19 Cases: Results from the PRECOVID study in Spain. International Journal of Environmental Research and Public Health, 17(14), 5171. https:\/\/doi.org\/10.3390\/IJERPH17145171","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"6844_CR42","unstructured":"Public Health England. (2020). Deaths of people identified as having learning disabilities with COVID-19 in England in the spring of 2020."},{"issue":"1","key":"6844_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12982-021-00100-9\/FIGURES\/10","volume":"18","author":"E Rahimi","year":"2021","unstructured":"Rahimi, E., & HashemiNazari, S. S. (2021). A detailed explanation and graphical representation of the Blinder-Oaxaca decomposition method with its application in health inequalities. Emerging Themes in Epidemiology, 18(1), 1\u201315. https:\/\/doi.org\/10.1186\/S12982-021-00100-9\/FIGURES\/10","journal-title":"Emerging Themes in Epidemiology"},{"issue":"5","key":"6844_CR44","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1093\/IJE\/DYAA140","volume":"49","author":"M Reilev","year":"2020","unstructured":"Reilev, M., Kristensen, K. B., Potteg\u00e5rd, A., Lund, L. C., Hallas, J., Ernst, M. T., Christiansen, C. F., S\u00f8rensen, H. T., Johansen, N. B., Brun, N. C., Voldstedlund, M., St\u00f8vring, H., Thomsen, M. K., Christensen, S., Gubbels, S., Krause, T. G., M\u00f8lbak, K., & Thomsen, R. W. (2020). Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort. International Journal of Epidemiology, 49(5), 1468\u20131481. https:\/\/doi.org\/10.1093\/IJE\/DYAA140","journal-title":"International Journal of Epidemiology"},{"issue":"6","key":"6844_CR45","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/JCPP.13505","volume":"63","author":"G Russell","year":"2022","unstructured":"Russell, G., Stapley, S., Newlove-Delgado, T., Salmon, A., White, R., Warren, F., Pearson, A., & Ford, T. (2022). Time trends in autism diagnosis over 20 years: A UK population-based cohort study. Journal of Child Psychology and Psychiatry and Allied Disciplines, 63(6), 674\u2013682. https:\/\/doi.org\/10.1111\/JCPP.13505","journal-title":"Journal of Child Psychology and Psychiatry and Allied Disciplines"},{"issue":"1","key":"6844_CR46","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1192\/BJP.2020.167","volume":"218","author":"E Rydzewska","year":"2021","unstructured":"Rydzewska, E., Dunn, K., & Cooper, S. A. (2021). Umbrella systematic review of systematic reviews and meta-analyses on comorbid physical conditions in people with autism spectrum disorder. The British Journal of Psychiatry\u202f: THe Journal of Mental Science, 218(1), 10\u201319. https:\/\/doi.org\/10.1192\/BJP.2020.167","journal-title":"The British Journal of Psychiatry : THe Journal of Mental Science"},{"issue":"1","key":"6844_CR47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/1362361317709970\/ASSET\/IMAGES\/LARGE\/10.1177_1362361317709970-FIG3.JPEG","volume":"22","author":"Y Saqr","year":"2018","unstructured":"Saqr, Y., Braun, E., Porter, K., Barnette, D., & Hanks, C. (2018). Addressing medical needs of adolescents and adults with autism spectrum disorders in a primary care setting. Autism, 22(1), 51\u201361. https:\/\/doi.org\/10.1177\/1362361317709970\/ASSET\/IMAGES\/LARGE\/10.1177_1362361317709970-FIG3.JPEG","journal-title":"Autism"},{"issue":"4","key":"6844_CR48","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1177\/13623613211039662","volume":"26","author":"W Schott","year":"2022","unstructured":"Schott, W., Tao, S., Shea, L., & Drexel, D. A. (2022). Covid-19 Risk: Adult medicaid beneficiaries with autism, intellectual disability, and mental health conditions HHS public access. Autism, 26(4), 975\u2013987. https:\/\/doi.org\/10.1177\/13623613211039662","journal-title":"Autism"},{"key":"6844_CR49","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1186\/s12889-023-16993-x","volume":"23","author":"F Sosenko","year":"2023","unstructured":"Sosenko, F., Mackay, D., Pell, J. P., Hatton, C., Jani, B. D., Cairns, D., Ward, L., Henderson, A., Fleming, M., Nijhof, D., & Melville, C. (2023). CVD-COVID-UK\/COVID-IMPACT Consortium. Understanding covid-19 outcomes among people with intellectual disabilities in England. BMC Public Health, 23, 2099. https:\/\/doi.org\/10.1186\/s12889-023-16993-x","journal-title":"BMC Public Health"},{"issue":"5","key":"6844_CR50","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1542\/peds.2012-3774","volume":"132","author":"D Spencer","year":"2013","unstructured":"Spencer, D., Marshall, J., Post, B., Kulakodlu, M., Newschaffer, C., Dennen, T., Azocar, F., & Jain, A. (2013). Psychotropic medication use and polypharmacy in children with autism spectrum disorders. Pediatrics, 132(5), 833\u2013840. https:\/\/doi.org\/10.1542\/peds.2012-3774","journal-title":"Pediatrics"},{"issue":"6","key":"6844_CR51","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1192\/BJP.2021.22","volume":"218","author":"A Strydom","year":"2021","unstructured":"Strydom, A., Corcoran, E., & Rebillat, A. S. (2021). The COVID-19 pandemic should be last orders for poor care of people with neurodevelopmental disorders. The British Journal of Psychiatry, 218(6), 302\u2013304. https:\/\/doi.org\/10.1192\/BJP.2021.22","journal-title":"The British Journal of Psychiatry"},{"key":"6844_CR52","doi-asserted-by":"publisher","first-page":"113856","DOI":"10.1016\/J.PSYCHRES.2021.113856","volume":"299","author":"AA Toubasi","year":"2021","unstructured":"Toubasi, A. A., AbuAnzeh, R. B., Tawileh, H. B. A., Aldebei, R. H., & Alryalat, S. A. S. (2021). A meta-analysis: The mortality and severity of COVID-19 among patients with mental disorders. Psychiatry Research, 299, 113856. https:\/\/doi.org\/10.1016\/J.PSYCHRES.2021.113856","journal-title":"Psychiatry Research"},{"key":"6844_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(21)00232-7","author":"B Vai","year":"2021","unstructured":"Vai, B., Mazza, M. G., Benedetti, F., Centro, F., Raffaele, S., Vai, B., Mazza, M. G., DelliColli, C., Foiselle, M., Allen, B., Benedetti, F., Borsini, A., Dias, M. C., Tamouza, R., Leboyer, M., Benros, M. E., Branchi, I., Fusar-Poli, P., & De Picker, L. J. (2021). Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: A systematic review and meta-analysis. The Lancet Psychiatry. https:\/\/doi.org\/10.1016\/S2215-0366(21)00232-7","journal-title":"The Lancet Psychiatry"},{"issue":"4","key":"6844_CR54","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/S40801-016-0096-Z\/TABLES\/5","volume":"3","author":"R Vohra","year":"2016","unstructured":"Vohra, R., Madhavan, S., Sambamoorthi, U., StPeter, C., Poe, S., Dwibedi, N., & Ajmera, M. (2016). Prescription Drug Use and Polypharmacy Among Medicaid-Enrolled Adults with Autism: A Retrospective Cross-Sectional Analysis. Drugs - Real World Outcomes, 3(4), 409\u2013425. https:\/\/doi.org\/10.1007\/S40801-016-0096-Z\/TABLES\/5","journal-title":"Drugs - Real World Outcomes"},{"issue":"2","key":"6844_CR55","doi-asserted-by":"publisher","first-page":"e3377","DOI":"10.1002\/DMRR.3377","volume":"37","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y., Chi, J., Lv, W., & Wang, Y. (2021). Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes\/metabolism Research and Reviews, 37(2), e3377. https:\/\/doi.org\/10.1002\/DMRR.3377","journal-title":"Diabetes\/metabolism Research and Reviews"}],"container-title":["Journal of Autism and Developmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10803-025-06844-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10803-025-06844-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10803-025-06844-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:42:56Z","timestamp":1792590176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10803-025-06844-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":55,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["6844"],"URL":"https:\/\/doi.org\/10.1007\/s10803-025-06844-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.02.23.24303274","asserted-by":"object"}]},"ISSN":["0162-3257","1573-3432"],"issn-type":[{"value":"0162-3257","type":"print"},{"value":"1573-3432","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"12 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The North-East \u2013 Newcastle and North Tyneside 2 research ethics committee provided ethical approval for the CVD-COVID-UK\/COVID-IMPACT research programme (REC No 20\/NE\/0161) to access, within secure trusted research environments, unconsented, whole-population, de-identified data from electronic health records collected as part of patients\u2019 routine healthcare. The need for informed consent was waived by the North-East \u2013 Newcastle and North Tyneside 2 research ethics committee. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Ethical Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}